Safety and Effectiveness of Cinnomer ® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study.

Abdorreza Naser MoghadasiFereshteh AshtariSeyed Mohammad BaghbanianVahid ShaygannejadNassim AnjidaniFereshteh GhadiriBehnaz SedighiMorteza SaeidiHamed AmirifardHormoz AyromlouNahid Beladi MoghadamMohammad Bagher RanjbarMasoume NazeriZahra NiknamFardin FarajiAfsaneh AfsordeMohammad Ali Sahraian

Published in: Archives of Iranian medicine (2023)

is effective with respect to clinical outcomes and from the patient's perspective and in reducing MRI-measured MS activity.

Keyphrases

mass spectrometry
randomized controlled trial
magnetic resonance imaging
contrast enhanced
case report
multiple sclerosis
depressive symptoms
systematic review
ms ms
sleep quality
diffusion weighted imaging